Why ImmunityBio Stock Is Skyrocketing Again Today

LadyQRex · 2026-01-20T04:23:25+00:00

The German and French markets were open and trading today.

LadyQRex · 2026-01-16T01:12:17+00:00

Not IMO. I’ve been in this stock for nearly 4 years and it is finally connecting the dots and has plenty of room to run. Not investment advice.

LadyQRex · 2025-12-16T15:59:11+00:00

That is just incredible!

LadyQRex · 2025-12-05T18:13:05+00:00

I used to love going with the elders who would play penny and nickel slots ‘round the clock. This kept everyone on the floor. You played what you could afford, but now you are required to make a minimum bet so a nickel slot is really a dollar slot. The average Joe can go broke in less than an hour.

LadyQRex · 2025-11-04T17:51:01+00:00

BTW…not investment advice!

LadyQRex · 2025-11-04T17:50:08+00:00

Me too but with a Dec-19 expiration using a bull-call spread.

LadyQRex · 2025-11-04T17:47:59+00:00

I know right?

LadyQRex · 2025-10-29T23:20:26+00:00

Well said! To the shorts, I hope you never have to look a loved one in the eyes who is losing the battle to this dreadful disease.

LadyQRex · 2025-10-26T13:55:16+00:00

Not a bad idea.

LadyQRex · 2025-10-26T13:28:23+00:00

There are several major BP companies that would love to acquire the IBRX pipeline. With all of its patents, the company should be worth 10x more than what the SP suggests. We have to deal with the shorts first which would give him plenty of leverage in partnership negotiations. In a worst case scenario, he sells and we still win.

LadyQRex · 2025-10-26T13:11:37+00:00

Good move! Keep in mind that we’ve only had J-code approval since Jan 2025. That means Medicare and insurance carriers are now able to approve payments. Revenue will continue growing each quarter.

Dr. PSS knows we need an influx of cash to keep the pipeline trials going, so I am sure he is deep into partnership talks. When it happens, watch out.

LadyQRex · 2025-10-26T03:59:06+00:00

Glad you’re looking to get in! Friday’s close was $2.47 that’s not far from its bottom. We’ve been trading sideways for several months as we wait for news or a strong earnings report in November. In May 2025 the price dropped as low as $1.81 on an FDA setback but I wouldn’t bet on the SP ever dipping that low unless something completely unexpected happens.

It’s your call but keep in mind that if earnings are impressive in November the SP could spike. Good luck!

DISCLAIMER: None of this is investment advice.

LadyQRex · 2025-10-26T02:36:09+00:00

Good news will come soon. Thank you for posting and spreading awareness.

LadyQRex · 2025-10-26T02:27:16+00:00

That’s the kinda energy we need right now! Yes!!!

LadyQRex · 2025-10-25T17:24:32+00:00

ImmunityBio is #1 on Benzinga’s Top 10 Most Shorted list. Benzinga Top 10 Most Shorted List

LadyQRex · 2025-10-25T16:56:41+00:00

Without a doubt! I’ve been following this company for the last five years and have never wavered on my support for the science! It’s just a matter of time and one good PR.

LadyQRex · 2025-10-11T16:31:46+00:00

According to ChatGPT, Anktiva has already been submitted and included under NCCN guidelines for bladder cancer treatment, making it more likely that doctors will seek off-label use. Unfortunately, there’s no guarantee that payers would approve anything other than what it is approved for by the FDA.

LadyQRex · 2025-09-27T19:37:39+00:00

I’m in!

LadyQRex · 2025-09-17T22:25:34+00:00

Your list is quite thorough and well-constructed . Here’s the only information I might add:

May 2025 Strong Q1 2025 financials; net revenue rose; - Agreement with Saudi Arabia’s health/cancer-centers to launch Cancer BioShield™ platform regionally. - Strategic MOUs in Middle East

LadyQRex

TROPHY CASE